1-5 of 5
Simon P. Robinson
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Noninvasive Imaging of Cycling Hypoxia in Head and Neck Cancer Using Intrinsic Susceptibility MRI

Rafal Panek, Liam Welsh, Lauren C.J. Baker, Maria A. Schmidt, Kee H. Wong, Angela M. Riddell, Dow-Mu Koh, Alex Dunlop, Dualta Mcquaid, James A. d'Arcy, Shreerang A. Bhide, Kevin J. Harrington, Christopher M. Nutting, Georgina Hopkinson, Cheryl Richardson, Carol Box, Suzanne A. Eccles, Martin O. Leach, Simon P. Robinson, Kate L. Newbold
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2017) 23 (15): 4233–4241.
https://doi.org/10.1158/1078-0432.CCR-16-1209
Published: 01 August 2017
View article titled, Noninvasive Imaging of Cycling Hypoxia in Head and Neck Cancer Using Intrinsic Susceptibility MRI
Open the PDF for Noninvasive Imaging of Cycling Hypoxia in Head and Neck Cancer Using Intrinsic Susceptibility MRI in another window
Includes: Supplementary data
Journal Articles

Cyclin-Dependent Kinase Inhibitor AT7519 as a Potential Drug for MYCN-Dependent Neuroblastoma

M. Emmy M. Dolman, Evon Poon, Marli E. Ebus, Ilona J.M. den Hartog, Carel J.M. van Noesel, Yann Jamin, Albert Hallsworth, Simon P. Robinson, Kevin Petrie, Rolf W. Sparidans, Robbert J. Kok, Rogier Versteeg, Huib N. Caron, Louis Chesler, Jan J. Molenaar
Journal: Clinical Cancer Research
Clin Cancer Res (2015) 21 (22): 5100–5109.
https://doi.org/10.1158/1078-0432.CCR-15-0313
Published: 12 November 2015
View article titled, Cyclin-Dependent Kinase Inhibitor AT7519 as a Potential Drug for MYCN-Dependent Neuroblastoma
Open the PDF for Cyclin-Dependent Kinase Inhibitor AT7519 as a Potential Drug for MYCN-Dependent Neuroblastoma in another window
Includes: Supplementary data
Journal Articles

CCT244747 Is a Novel Potent and Selective CHK1 Inhibitor with Oral Efficacy Alone and in Combination with Genotoxic Anticancer Drugs

Mike I. Walton, Paul D. Eve, Angela Hayes, Melanie R. Valenti, Alexis K. De Haven Brandon, Gary Box, Albert Hallsworth, Elizabeth L. Smith, Kathy J. Boxall, Michael Lainchbury, Thomas P. Matthews, Yann Jamin, Simon P. Robinson, G. Wynne Aherne, John C. Reader, Louis Chesler, Florence I. Raynaud, Suzanne A. Eccles, Ian Collins, Michelle D. Garrett
Journal: Clinical Cancer Research
Clin Cancer Res (2012) 18 (20): 5650–5661.
https://doi.org/10.1158/1078-0432.CCR-12-1322
Published: 14 October 2012
View article titled, CCT244747 Is a Novel Potent and Selective CHK1 Inhibitor with Oral Efficacy Alone and in Combination with Genotoxic Anticancer Drugs
Open the PDF for CCT244747 Is a Novel Potent and Selective CHK1 Inhibitor with Oral Efficacy Alone and in Combination with Genotoxic Anticancer Drugs in another window
Includes: Supplementary data
Journal Articles

Tumor Dose Response to the Vascular Disrupting Agent, 5,6-Dimethylxanthenone-4-Acetic Acid, Using In vivo Magnetic Resonance Spectroscopy

Lesley D. McPhail, Yuen-Li Chung, Basetti Madhu, Simon Clark, John R. Griffiths, Lloyd R. Kelland, Simon P. Robinson
Journal: Clinical Cancer Research
Clin Cancer Res (2005) 11 (10): 3705–3713.
https://doi.org/10.1158/1078-0432.CCR-04-2504
Published: 16 May 2005
View article titled, Tumor Dose Response to the Vascular Disrupting Agent, 5,6-Dimethylxanthenone-4-Acetic Acid, Using <em>In vivo</em> Magnetic Resonance Spectroscopy
Open the PDF for Tumor Dose Response to the Vascular Disrupting Agent, 5,6-Dimethylxanthenone-4-Acetic Acid, Using <em>In vivo</em> Magnetic Resonance Spectroscopy in another window
Journal Articles

Effects of a New Clinically Relevant Antiestrogen (GW5638) Related to Tamoxifen on Breast and Endometrial Cancer Growth in Vivo

Rita C. Dardes, Ruth M. O’Regan, Csaba Gajdos, Simon P. Robinson, David Bentrem, Alex De Los Reyes, V. Craig Jordan
Journal: Clinical Cancer Research
Clin Cancer Res (2002) 8 (6): 1995–2001.
Published: 01 June 2002
View article titled, Effects of a New Clinically Relevant Antiestrogen (GW5638) Related to Tamoxifen on Breast and Endometrial Cancer Growth <em>in Vivo</em>
Open the PDF for Effects of a New Clinically Relevant Antiestrogen (GW5638) Related to Tamoxifen on Breast and Endometrial Cancer Growth <em>in Vivo</em> in another window